Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration

PLoS One. 2015 May 11;10(5):e0126636. doi: 10.1371/journal.pone.0126636. eCollection 2015.


Worldwide, age-related macular degeneration (AMD) is a serious threat to vision loss in individuals over 50 years of age with a pooled prevalence of approximately 9%. For 2020, the number of people afflicted with this condition is estimated to reach 200 million. While AMD lesions presenting as geographic atrophy (GA) show high inter-individual variability, only little is known about prognostic factors. Here, we aimed to elucidate the contribution of clinical, demographic and genetic factors on GA progression. Analyzing the currently largest dataset on GA lesion growth (N = 388), our findings suggest a significant and independent contribution of three factors on GA lesion growth including at least two genetic factors (ARMS2_rs10490924 [P < 0.00088] and C3_rs2230199 [P < 0.00015]) as well as one clinical component (presence of GA in the fellow eye [P < 0.00023]). These correlations jointly explain up to 7.2% of the observed inter-individual variance in GA lesion progression and should be considered in strategy planning of interventional clinical trials aimed at evaluating novel treatment options in advanced GA due to AMD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Disease Progression
  • Fluorescein Angiography
  • Follow-Up Studies
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genotype
  • Geographic Atrophy / diagnosis*
  • Geographic Atrophy / genetics*
  • Humans
  • Proteins / genetics


  • ARMS2 protein, human
  • Proteins